Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
BMC Cancer|July 25, 2024
AT-0174, a novel dual IDO1/TDO2 enzyme inhibitor, synergises with temozolomide to improve survival in an orthotopic mouse model of glioblastomaMichael J Bickerdike, Imane Nafia, Alban Bessede, et al.Marine Drugs|January 20, 2022
Fucoidan Independently Enhances Activity in Human Immune Cells and Has a Cytostatic Effect on Prostate Cancer Cells in the Presence of NivolumabAh Young Park, Imane Nafia, Damien N Stringer, et al.Glia|May 5, 2006
Glutamate leakage from a compartmentalized intracellular metabolic pool and activation of the lipoxygenase pathway mediate oxidative astrocyte death by reversed glutamate transportDiane B Re, Imane Nafia, Christophe Melon, et al.Neurobiology of Disease|February 1, 2014
Progressive Parkinsonism by acute dysfunction of excitatory amino acid transporters in the rat substantia nigraMaxime Assous, Laurence Had-Aissouni, Paolo Gubellini, et al.Journal of Neurochemistry|November 29, 2007
Preferential vulnerability of mesencephalic dopamine neurons to glutamate transporter dysfunctionImane Nafia, Diane B Re, Frédérique Masmejean, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2023
Upregulation of Indoleamine 2,3-Dioxygenase 1 in Tumor Cells and Tertiary Lymphoid Structures is a Hallmark of Inflamed Non-Small Cell Lung CancerAlban Bessede, Florent Peyraud, Sylvestre Le Moulec, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2023
TROP2 Is Associated with Primary Resistance to Immune Checkpoint Inhibition in Patients with Advanced Non-Small Cell Lung CancerAlban Bessede, Florent Peyraud, Benjamin Besse, et al.Frontiers in Immunology|March 21, 2020
IDO Targeting in Sarcoma: Biological and Clinical ImplicationsImane Nafia, Maud Toulmonde, Doriane Bortolotto, et al.Pageof 1